ICD-10-CM 2027
ICD-10 code for MOGAD
Myelin oligodendrocyte glycoprotein antibody disease
From the official ICD-10-CM alphabetic index entry “MOGAD (myelin oligodendrocyte glycoprotein antibody disease)”. Page updated September 29, 2026.
About coding MOGAD
The ICD-10-CM code for MOGAD is G37.81 (Myelin oligodendrocyte glycoprotein antibody disease).
Within G37.8 (other specified demyelinating diseases of central nervous system), G37.81 is specifically for Myelin oligodendrocyte glycoprotein antibody disease. Related codes cover other specified demyelinating diseases of central nervous system (G37.89).
As a secondary diagnosis it is a CC (complication or comorbidity), which can move an inpatient stay into the "with CC" MS-DRG of its family, unless the principal diagnosis excludes it.
In MS-DRG v44.0, it is part of the grouping logic for DRG 058 (Multiple Sclerosis and Cerebellar Ataxia with MCC, relative weight 1.8438), DRG 059 (Multiple Sclerosis and Cerebellar Ataxia with CC, relative weight 1.2002) and DRG 060 (Multiple Sclerosis and Cerebellar Ataxia without CC/MCC, relative weight 0.9247), in MDC 01 (Diseases and Disorders of the Nervous System), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.
Common questions about MOGAD ICD-10 codes
What is the ICD-10 code for MOGAD?
- G37.81 — Myelin oligodendrocyte glycoprotein antibody disease.
Is G37.81 billable?
- Yes. G37.81 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
Can G37.81 be used as a principal diagnosis?
- Yes. The Medicare Code Editor doesn't restrict G37.81 as a principal diagnosis.
Is G37.81 a CC or MCC?
- G37.81 is a CC (complication or comorbidity) under MS-DRG v44.0, unless excluded by the principal diagnosis.